Clinical Trial Update: A Pharmaco-epidemiological Study of Short Patients Born Small for Gestational Age (SGA), Treated With Saizen® (Recombinant Somatropin)

View source ↗

Summary

This clinical trial update summarizes a pharmaco-epidemiological study of infants born small for gestational age treated with Saizen (recombinant somatropin). T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small For Gestational Age

Drugs mentioned

• Saizen (somatropin)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Infant, Small for Gestational Age | Status: COMPLETED